Revogliform 1/0.2 Tablet SR
Marketer
Dr.Revmax Healthcare
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)
Overview Revogliform 1/0.2 Tablet SR
Voglibose/Metformin extended-release tablets are antidiabetic medications combining two drugs to manage type 2 diabetes in adults. They help regulate blood glucose. These tablets should be ingested with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial, even with controlled blood sugar, as abrupt cessation can elevate glucose levels, potentially causing kidney complications, vision impairment, neuropathy, and limb loss. This medication is part of a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle significantly impacts diabetes control. Hypoglycemia (low blood sugar) is the most frequent side effect, characterized by sweating, dizziness, headache, and tremors. Maintain regular mealtimes and carry a rapid-acting glucose source (e.g., sugary snacks, juice) to counter this. Alcohol increases hypoglycemia risk and should be limited. Additional potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, swelling, blurred vision, fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe liver or kidney disease. Individuals with a history of heart disease should inform their physician before commencing treatment. Pregnant or lactating women should consult their doctor. Regular blood glucose monitoring and periodic blood tests (blood counts, liver function) are recommended.
Uses of Revogliform 1/0.2 Tablet SR
Managing Type 2 Diabetes
Major Benefits of Revogliform 1/0.2 Tablet SR:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Revogliform 1/0.2 Tablet SR on an empty stomach.
Common Side effects of Revogliform 1/0.2 Tablet SR:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Revogliform 1/0.2 Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Revogliform 1/0.2 Tablet SR whole; do not break, crush, or chew it. Administer on an empty stomach.
How Revogliform 1/0.2 Tablet SR works:
Revogliform SR tablets (1 mg/0.2 mg) contain a triple combination of anti-diabetic agents.
SAFETY ADVICE
AlcoholUNSAFE
Combining Revogliform 1/0.2 Tablet SR and alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Using Revogliform 1/0.2 SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the potential benefits against these risks prior to prescription. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Revogliform 1/0.2mg tablet is likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving may be impaired if your blood glucose level is abnormally high or low. Refrain from driving should such symptoms arise.
KidneyUNSAFE
Employing Revogliform 1/0.2 Tablet SR is likely inadvisable for individuals with kidney impairment and should be eschewed. Medical advice is recommended. Furthermore, its use is discouraged in patients exhibiting severe kidney dysfunction.
LiverCAUTION
Patients with liver impairment should use Revogliform 1/0.2 Tablet SR cautiously, potentially requiring dose modification. Consult a physician. A reduced initial dose is typically prescribed for individuals with mild to moderate hepatic dysfunction; the medication is contraindicated in those with severe liver disease.
What if you forget to take Revogliform 1/0.2 Tablet SR :
Should you forget to take your Revogliform 1/0.2 Tablet SR, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Revogliform 1/0.2 Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently